POM Stock: Price, Forecast, Financials & AI Analysis

Loading chart...

High

1.660

Open

1.660

VWAP

1.51

Vol

20.83K

Mkt Cap

11.93M

Low

1.430

Amount

31.53K

EV/EBITDA(TTM)

Total Shares

7.46M

77.87M

EV/OCF(TTM)

P/S(TTM)

PomDoctor Ltd is a holding company principally engaged in the operation of online medical services platform for chronic diseases. The Company operates its businesses through two segments. The Internet Hospital segment includes providing online follow-up consultations and online prescription renewal service to customers and also sells prescription to customers through the website and apps. The Pharmaceutical Supply Chain segment includes pharmacy retail sales and wholesale. The Company mainly conducts its business in the domestic market.

Events Timeline

(ET)

2026-02-02

06:10:00

PomDoctor Receives Nasdaq Deficiency Notice

2025-12-10 (ET)

2025-12-10

09:40:00

Pepco Holdings, Inc. Trading Resumes

2025-12-10

09:40:00

Pepco Holdings Trading Halted Due to Volatility

2025-10-08 (ET)

2025-10-08

11:36:22

PomDoctor Debuts at $4.50 After IPO Set at $4.00 per Share

2025-10-08

08:03:04

PomDoctor Sets IPO Price at $4.00 for 5 Million Shares

News

4.5

07-02PRnewswire

POMDOCTOR Transitions to Predictive Healthcare Infrastructure Provider

8.5

06-17seekingalpha

Pomdoctor Adjusts ADS Ratio to 1-for-3

8.5

06-17PRnewswire

POMDOCTOR Announces ADS Ratio Change

8.5

06-17Newsfilter

POMDOCTOR Announces ADS Ratio Change

8.5

05-28seekingalpha

Pomdoctor Changes ADS Ratio to 1:3

9.5

05-15seekingalpha

Pomdoctor Limited Reports 16.7% Revenue Growth in FY 2025

Valuation Metrics

The current forward P/E ratio for PomDoctor Ltd (POM.O) is 0.00, compared to its 5-year average forward P/E of 0.00. For a more detailed relative valuation and DCF analysis to assess PomDoctor Ltd's fair value, Click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

0.00

Current PE

0.00

Overvalued PE

0.00

Undervalued PE

0.00

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

N/A

5Y Average EV/EBITDA

0.00

Current EV/EBITDA

0.00

Overvalued EV/EBITDA

0.00

Undervalued EV/EBITDA

0.00

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.00

Current PS

0.00

Overvalued PS

0.00

Undervalued PS

0.00

Financials

AI Analysis

Annual

Quarterly

Related Community Screener

under $20 stocks

Intellectia · 3048 candidates

Price: <= $20.00

Ticker

Name

Market Cap$

HAO

Haoxi Health Technology Ltd

2.42M

EZGO

EZGO Technologies Ltd

670.40K

ADTX

Aditxt Inc

76.16K

PPCB

Propanc Biopharma Inc

1.47M

LZMH

LZ Technology Holdings Ltd

15.12M

MEHA

Functional Brands Inc

2.13M

stocks bearish for a week

Intellectia · 2207 candidates

Moving Average Relationship: PriceBelowMA5, PriceBelowMA20, PriceCrossDownMA5, PriceCrossDownMA20Week Price Change Pct: <= $0.00

Ticker

Name

Market Cap$

EZGO

EZGO Technologies Ltd

39.68M

GDC

GD Culture Group Ltd

9.72M

ONEG

OneConstruction Group Ltd

22.40M

ENGN

enGene Therapeutics Inc

592.86M

POM

PomDoctor Ltd

63.30M

EMBC

Embecta Corp

215.95M

stocks under $1 that will be bullish today

Intellectia · 96 candidates

Price: <= $1.00

Ticker

Name

Market Cap$

SXTC

China SXT Pharmaceuticals Inc

11.70M

SAFX

XCF Global Inc

28.75M

MKDW

MKDWELL Tech Inc

14.59M

SRXH

Srx Health Solutions Inc

11.89M

ADIL

Adial Pharmaceuticals Inc

6.04M

GRI

GRI Bio Inc

2.26M

stocks under $0.50 with an rsi under 20

Intellectia · 33 candidates

Price: <= $0.50Rsi Category: oversold

Ticker

Name

Market Cap$

MTEN

Mingteng International Corp Inc

5.55M

ATPC

Agape ATP Corp

4.10M

SXTC

China SXT Pharmaceuticals Inc

11.70M

CCTG

CCSC Technology International Holdings Ltd

3.84M

APLT

Applied Therapeutics Inc

14.63M

ZJYL

Jin Medical International Ltd

19.82M

stocks under $1 with an rsi under 20

Intellectia · 53 candidates

Price: <= $1.00Rsi Category: oversold

Ticker

Name

Market Cap$

AIIO

Robo.ai Inc

89.22M

PSTV

Plus Therapeutics Inc

52.05M

HURA

TuHURA Biosciences Inc

41.71M

XLO

Xilio Therapeutics Inc

40.33M

POM

PomDoctor Ltd

35.21M

OTLK

Outlook Therapeutics Inc

32.44M

stocks under $1 with an rsi under 10

Intellectia · 53 candidates

Price: <= $1.00Rsi Category: oversold

Ticker

Name

Market Cap$

AIIO

Robo.ai Inc

89.22M

PSTV

Plus Therapeutics Inc

52.05M

HURA

TuHURA Biosciences Inc

41.71M

XLO

Xilio Therapeutics Inc

40.33M

POM

PomDoctor Ltd

35.21M

OTLK

Outlook Therapeutics Inc

32.44M

stocks under $1 with an rsi under 15

Intellectia · 53 candidates

Price: <= $1.00Rsi Category: oversold

Ticker

Name

Market Cap$

MTEN

Mingteng International Corp Inc

5.55M

ATPC

Agape ATP Corp

4.10M

SXTC

China SXT Pharmaceuticals Inc

11.70M

CCTG

CCSC Technology International Holdings Ltd

3.84M

APLT

Applied Therapeutics Inc

14.63M

ZJYL

Jin Medical International Ltd

19.82M

stovks to buy on wed from 20 to 40 cents

Intellectia · 81 candidates

Price: $0.20 - $0.40

Ticker

Name

Market Cap$

SGMO

Sangamo Therapeutics Inc

127.97M

IXHL

Incannex Healthcare Inc

123.43M

GPUS

Hyperscale Data Inc

96.48M

AURE

Aurelion Inc

95.26M

AIIO

Robo.ai Inc

89.22M

ZONE

CleanCore Solutions Inc

79.36M

Whales Holding POM

Trading Trends

People Also Watch

Frequently Asked Questions

What is PomDoctor Ltd (POM) stock price today?

The current price of POM is 1.45 USD — it has decreased -9.38

What is PomDoctor Ltd (POM)'s business?

What is the price predicton of POM Stock?

Wall Street analysts forecast POM stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for POM is USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.